The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Albumin (as Excipient) Market Research Report 2025
Synopsis
The global market for Albumin (as Excipient) was valued at US$ 4882 million in the year 2024 and is projected to reach a revised size of US$ 7346 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The industry"s leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Albumin (as Excipient), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albumin (as Excipient).
The Albumin (as Excipient) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Albumin (as Excipient) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albumin (as Excipient) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
Segment by Type
Human Serum Albumin
Recombinant Albumin
Segment by Application
Cell Culture Media
Medical Supplements
Therapeutics
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Albumin (as Excipient) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Albumin (as Excipient) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Albumin (as Excipient) was valued at US$ 4882 million in the year 2024 and is projected to reach a revised size of US$ 7346 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The industry"s leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Albumin (as Excipient), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albumin (as Excipient).
The Albumin (as Excipient) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Albumin (as Excipient) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albumin (as Excipient) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
Segment by Type
Human Serum Albumin
Recombinant Albumin
Segment by Application
Cell Culture Media
Medical Supplements
Therapeutics
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Albumin (as Excipient) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Albumin (as Excipient) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Albumin (as Excipient) Market Overview
1.1 Product Definition
1.2 Albumin (as Excipient) by Type
1.2.1 Global Albumin (as Excipient) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Human Serum Albumin
1.2.3 Recombinant Albumin
1.3 Albumin (as Excipient) by Application
1.3.1 Global Albumin (as Excipient) Market Value by Application (2024 VS 2031)
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Therapeutics
1.4 Global Albumin (as Excipient) Market Size Estimates and Forecasts
1.4.1 Global Albumin (as Excipient) Revenue 2020-2031
1.4.2 Global Albumin (as Excipient) Sales 2020-2031
1.4.3 Global Albumin (as Excipient) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Albumin (as Excipient) Market Competition by Manufacturers
2.1 Global Albumin (as Excipient) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Albumin (as Excipient) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Albumin (as Excipient) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Albumin (as Excipient), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Albumin (as Excipient), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Albumin (as Excipient), Product Type & Application
2.7 Global Key Manufacturers of Albumin (as Excipient), Date of Enter into This Industry
2.8 Global Albumin (as Excipient) Market Competitive Situation and Trends
2.8.1 Global Albumin (as Excipient) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Albumin (as Excipient) Players Market Share by Revenue
2.8.3 Global Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Albumin (as Excipient) Market Scenario by Region
3.1 Global Albumin (as Excipient) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Albumin (as Excipient) Sales by Region: 2020-2031
3.2.1 Global Albumin (as Excipient) Sales by Region: 2020-2025
3.2.2 Global Albumin (as Excipient) Sales by Region: 2026-2031
3.3 Global Albumin (as Excipient) Revenue by Region: 2020-2031
3.3.1 Global Albumin (as Excipient) Revenue by Region: 2020-2025
3.3.2 Global Albumin (as Excipient) Revenue by Region: 2026-2031
3.4 North America Albumin (as Excipient) Market Facts & Figures by Country
3.4.1 North America Albumin (as Excipient) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Albumin (as Excipient) Sales by Country (2020-2031)
3.4.3 North America Albumin (as Excipient) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Albumin (as Excipient) Market Facts & Figures by Country
3.5.1 Europe Albumin (as Excipient) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Albumin (as Excipient) Sales by Country (2020-2031)
3.5.3 Europe Albumin (as Excipient) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Albumin (as Excipient) Market Facts & Figures by Region
3.6.1 Asia Pacific Albumin (as Excipient) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Albumin (as Excipient) Sales by Region (2020-2031)
3.6.3 Asia Pacific Albumin (as Excipient) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Albumin (as Excipient) Market Facts & Figures by Country
3.7.1 Latin America Albumin (as Excipient) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Albumin (as Excipient) Sales by Country (2020-2031)
3.7.3 Latin America Albumin (as Excipient) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Albumin (as Excipient) Market Facts & Figures by Country
3.8.1 Middle East and Africa Albumin (as Excipient) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Albumin (as Excipient) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Albumin (as Excipient) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Albumin (as Excipient) Sales by Type (2020-2031)
4.1.1 Global Albumin (as Excipient) Sales by Type (2020-2025)
4.1.2 Global Albumin (as Excipient) Sales by Type (2026-2031)
4.1.3 Global Albumin (as Excipient) Sales Market Share by Type (2020-2031)
4.2 Global Albumin (as Excipient) Revenue by Type (2020-2031)
4.2.1 Global Albumin (as Excipient) Revenue by Type (2020-2025)
4.2.2 Global Albumin (as Excipient) Revenue by Type (2026-2031)
4.2.3 Global Albumin (as Excipient) Revenue Market Share by Type (2020-2031)
4.3 Global Albumin (as Excipient) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Albumin (as Excipient) Sales by Application (2020-2031)
5.1.1 Global Albumin (as Excipient) Sales by Application (2020-2025)
5.1.2 Global Albumin (as Excipient) Sales by Application (2026-2031)
5.1.3 Global Albumin (as Excipient) Sales Market Share by Application (2020-2031)
5.2 Global Albumin (as Excipient) Revenue by Application (2020-2031)
5.2.1 Global Albumin (as Excipient) Revenue by Application (2020-2025)
5.2.2 Global Albumin (as Excipient) Revenue by Application (2026-2031)
5.2.3 Global Albumin (as Excipient) Revenue Market Share by Application (2020-2031)
5.3 Global Albumin (as Excipient) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Company Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Albumin (as Excipient) Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Albumin (as Excipient) Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Company Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Takeda Albumin (as Excipient) Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Octapharma Albumin (as Excipient) Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Hualan Bio
6.5.1 Hualan Bio Company Information
6.5.2 Hualan Bio Description and Business Overview
6.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hualan Bio Albumin (as Excipient) Product Portfolio
6.5.5 Hualan Bio Recent Developments/Updates
6.6 CBPO
6.6.1 CBPO Company Information
6.6.2 CBPO Description and Business Overview
6.6.3 CBPO Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CBPO Albumin (as Excipient) Product Portfolio
6.6.5 CBPO Recent Developments/Updates
6.7 Shanghai RAAS
6.7.1 Shanghai RAAS Company Information
6.7.2 Shanghai RAAS Description and Business Overview
6.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shanghai RAAS Albumin (as Excipient) Product Portfolio
6.7.5 Shanghai RAAS Recent Developments/Updates
6.8 Kedrion
6.8.1 Kedrion Company Information
6.8.2 Kedrion Description and Business Overview
6.8.3 Kedrion Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Kedrion Albumin (as Excipient) Product Portfolio
6.8.5 Kedrion Recent Developments/Updates
6.9 LFB Group
6.9.1 LFB Group Company Information
6.9.2 LFB Group Description and Business Overview
6.9.3 LFB Group Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 LFB Group Albumin (as Excipient) Product Portfolio
6.9.5 LFB Group Recent Developments/Updates
6.10 Albumedix
6.10.1 Albumedix Company Information
6.10.2 Albumedix Description and Business Overview
6.10.3 Albumedix Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Albumedix Albumin (as Excipient) Product Portfolio
6.10.5 Albumedix Recent Developments/Updates
6.11 Biotest
6.11.1 Biotest Company Information
6.11.2 Biotest Description and Business Overview
6.11.3 Biotest Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Biotest Albumin (as Excipient) Product Portfolio
6.11.5 Biotest Recent Developments/Updates
6.12 Merck
6.12.1 Merck Company Information
6.12.2 Merck Description and Business Overview
6.12.3 Merck Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Merck Albumin (as Excipient) Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Ventria (InVitria)
6.13.1 Ventria (InVitria) Company Information
6.13.2 Ventria (InVitria) Description and Business Overview
6.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ventria (InVitria) Albumin (as Excipient) Product Portfolio
6.13.5 Ventria (InVitria) Recent Developments/Updates
6.14 HiMedia
6.14.1 HiMedia Company Information
6.14.2 HiMedia Description and Business Overview
6.14.3 HiMedia Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 HiMedia Albumin (as Excipient) Product Portfolio
6.14.5 HiMedia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Albumin (as Excipient) Industry Chain Analysis
7.2 Albumin (as Excipient) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Albumin (as Excipient) Production Mode & Process Analysis
7.4 Albumin (as Excipient) Sales and Marketing
7.4.1 Albumin (as Excipient) Sales Channels
7.4.2 Albumin (as Excipient) Distributors
7.5 Albumin (as Excipient) Customer Analysis
8 Albumin (as Excipient) Market Dynamics
8.1 Albumin (as Excipient) Industry Trends
8.2 Albumin (as Excipient) Market Drivers
8.3 Albumin (as Excipient) Market Challenges
8.4 Albumin (as Excipient) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Albumin (as Excipient) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Albumin (as Excipient) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Albumin (as Excipient) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Albumin (as Excipient) Sales (MT) of Key Manufacturers (2020-2025)
Table 5. Global Albumin (as Excipient) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Albumin (as Excipient) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Albumin (as Excipient) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Albumin (as Excipient) Average Price (USD/Kg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Albumin (as Excipient), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Albumin (as Excipient), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Albumin (as Excipient), Product Type & Application
Table 12. Global Key Manufacturers of Albumin (as Excipient), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Albumin (as Excipient) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albumin (as Excipient) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Albumin (as Excipient) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Albumin (as Excipient) Sales by Region (2020-2025) & (MT)
Table 18. Global Albumin (as Excipient) Sales Market Share by Region (2020-2025)
Table 19. Global Albumin (as Excipient) Sales by Region (2026-2031) & (MT)
Table 20. Global Albumin (as Excipient) Sales Market Share by Region (2026-2031)
Table 21. Global Albumin (as Excipient) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Albumin (as Excipient) Revenue Market Share by Region (2020-2025)
Table 23. Global Albumin (as Excipient) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Albumin (as Excipient) Revenue Market Share by Region (2026-2031)
Table 25. North America Albumin (as Excipient) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Albumin (as Excipient) Sales by Country (2020-2025) & (MT)
Table 27. North America Albumin (as Excipient) Sales by Country (2026-2031) & (MT)
Table 28. North America Albumin (as Excipient) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Albumin (as Excipient) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Albumin (as Excipient) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Albumin (as Excipient) Sales by Country (2020-2025) & (MT)
Table 32. Europe Albumin (as Excipient) Sales by Country (2026-2031) & (MT)
Table 33. Europe Albumin (as Excipient) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Albumin (as Excipient) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Albumin (as Excipient) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Albumin (as Excipient) Sales by Region (2020-2025) & (MT)
Table 37. Asia Pacific Albumin (as Excipient) Sales by Region (2026-2031) & (MT)
Table 38. Asia Pacific Albumin (as Excipient) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Albumin (as Excipient) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Albumin (as Excipient) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Albumin (as Excipient) Sales by Country (2020-2025) & (MT)
Table 42. Latin America Albumin (as Excipient) Sales by Country (2026-2031) & (MT)
Table 43. Latin America Albumin (as Excipient) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Albumin (as Excipient) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Albumin (as Excipient) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Albumin (as Excipient) Sales by Country (2020-2025) & (MT)
Table 47. Middle East and Africa Albumin (as Excipient) Sales by Country (2026-2031) & (MT)
Table 48. Middle East and Africa Albumin (as Excipient) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Albumin (as Excipient) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Albumin (as Excipient) Sales (MT) by Type (2020-2025)
Table 51. Global Albumin (as Excipient) Sales (MT) by Type (2026-2031)
Table 52. Global Albumin (as Excipient) Sales Market Share by Type (2020-2025)
Table 53. Global Albumin (as Excipient) Sales Market Share by Type (2026-2031)
Table 54. Global Albumin (as Excipient) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Albumin (as Excipient) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Albumin (as Excipient) Revenue Market Share by Type (2020-2025)
Table 57. Global Albumin (as Excipient) Revenue Market Share by Type (2026-2031)
Table 58. Global Albumin (as Excipient) Price (USD/Kg) by Type (2020-2025)
Table 59. Global Albumin (as Excipient) Price (USD/Kg) by Type (2026-2031)
Table 60. Global Albumin (as Excipient) Sales (MT) by Application (2020-2025)
Table 61. Global Albumin (as Excipient) Sales (MT) by Application (2026-2031)
Table 62. Global Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Table 63. Global Albumin (as Excipient) Sales Market Share by Application (2026-2031)
Table 64. Global Albumin (as Excipient) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Albumin (as Excipient) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Albumin (as Excipient) Revenue Market Share by Application (2020-2025)
Table 67. Global Albumin (as Excipient) Revenue Market Share by Application (2026-2031)
Table 68. Global Albumin (as Excipient) Price (USD/Kg) by Application (2020-2025)
Table 69. Global Albumin (as Excipient) Price (USD/Kg) by Application (2026-2031)
Table 70. CSL Company Information
Table 71. CSL Description and Business Overview
Table 72. CSL Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 73. CSL Albumin (as Excipient) Product
Table 74. CSL Recent Developments/Updates
Table 75. Grifols Company Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 78. Grifols Albumin (as Excipient) Product
Table 79. Grifols Recent Developments/Updates
Table 80. Takeda Company Information
Table 81. Takeda Description and Business Overview
Table 82. Takeda Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 83. Takeda Albumin (as Excipient) Product
Table 84. Takeda Recent Developments/Updates
Table 85. Octapharma Company Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 88. Octapharma Albumin (as Excipient) Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Hualan Bio Company Information
Table 91. Hualan Bio Description and Business Overview
Table 92. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 93. Hualan Bio Albumin (as Excipient) Product
Table 94. Hualan Bio Recent Developments/Updates
Table 95. CBPO Company Information
Table 96. CBPO Description and Business Overview
Table 97. CBPO Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 98. CBPO Albumin (as Excipient) Product
Table 99. CBPO Recent Developments/Updates
Table 100. Shanghai RAAS Company Information
Table 101. Shanghai RAAS Description and Business Overview
Table 102. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 103. Shanghai RAAS Albumin (as Excipient) Product
Table 104. Shanghai RAAS Recent Developments/Updates
Table 105. Kedrion Company Information
Table 106. Kedrion Description and Business Overview
Table 107. Kedrion Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 108. Kedrion Albumin (as Excipient) Product
Table 109. Kedrion Recent Developments/Updates
Table 110. LFB Group Company Information
Table 111. LFB Group Description and Business Overview
Table 112. LFB Group Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 113. LFB Group Albumin (as Excipient) Product
Table 114. LFB Group Recent Developments/Updates
Table 115. Albumedix Company Information
Table 116. Albumedix Description and Business Overview
Table 117. Albumedix Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 118. Albumedix Albumin (as Excipient) Product
Table 119. Albumedix Recent Developments/Updates
Table 120. Biotest Company Information
Table 121. Biotest Description and Business Overview
Table 122. Biotest Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 123. Biotest Albumin (as Excipient) Product
Table 124. Biotest Recent Developments/Updates
Table 125. Merck Company Information
Table 126. Merck Description and Business Overview
Table 127. Merck Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 128. Merck Albumin (as Excipient) Product
Table 129. Merck Recent Developments/Updates
Table 130. Ventria (InVitria) Company Information
Table 131. Ventria (InVitria) Description and Business Overview
Table 132. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 133. Ventria (InVitria) Albumin (as Excipient) Product
Table 134. Ventria (InVitria) Recent Developments/Updates
Table 135. HiMedia Company Information
Table 136. HiMedia Description and Business Overview
Table 137. HiMedia Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 138. HiMedia Albumin (as Excipient) Product
Table 139. HiMedia Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Albumin (as Excipient) Distributors List
Table 143. Albumin (as Excipient) Customers List
Table 144. Albumin (as Excipient) Market Trends
Table 145. Albumin (as Excipient) Market Drivers
Table 146. Albumin (as Excipient) Market Challenges
Table 147. Albumin (as Excipient) Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Albumin (as Excipient)
Figure 2. Global Albumin (as Excipient) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Albumin (as Excipient) Market Share by Type: 2024 & 2031
Figure 4. Human Serum Albumin Product Picture
Figure 5. Recombinant Albumin Product Picture
Figure 6. Global Albumin (as Excipient) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Albumin (as Excipient) Market Share by Application: 2024 & 2031
Figure 8. Cell Culture Media
Figure 9. Medical Supplements
Figure 10. Therapeutics
Figure 11. Global Albumin (as Excipient) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Albumin (as Excipient) Market Size (2020-2031) & (US$ Million)
Figure 13. Global Albumin (as Excipient) Sales (2020-2031) & (MT)
Figure 14. Global Albumin (as Excipient) Average Price (USD/Kg) & (2020-2031)
Figure 15. Albumin (as Excipient) Report Years Considered
Figure 16. Albumin (as Excipient) Sales Share by Manufacturers in 2024
Figure 17. Global Albumin (as Excipient) Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Albumin (as Excipient) Players: Market Share by Revenue in Albumin (as Excipient) in 2024
Figure 19. Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Albumin (as Excipient) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Albumin (as Excipient) Sales Market Share by Country (2020-2031)
Figure 22. North America Albumin (as Excipient) Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Albumin (as Excipient) Sales Market Share by Country (2020-2031)
Figure 26. Europe Albumin (as Excipient) Revenue Market Share by Country (2020-2031)
Figure 27. Germany Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Albumin (as Excipient) Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Albumin (as Excipient) Revenue Market Share by Region (2020-2031)
Figure 34. China Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Albumin (as Excipient) Sales Market Share by Country (2020-2031)
Figure 45. Latin America Albumin (as Excipient) Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Albumin (as Excipient) Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Albumin (as Excipient) Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Albumin (as Excipient) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Albumin (as Excipient) by Type (2020-2031)
Figure 55. Global Revenue Market Share of Albumin (as Excipient) by Type (2020-2031)
Figure 56. Global Albumin (as Excipient) Price (USD/Kg) by Type (2020-2031)
Figure 57. Global Sales Market Share of Albumin (as Excipient) by Application (2020-2031)
Figure 58. Global Revenue Market Share of Albumin (as Excipient) by Application (2020-2031)
Figure 59. Global Albumin (as Excipient) Price (USD/Kg) by Application (2020-2031)
Figure 60. Albumin (as Excipient) Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
